Back to Search
Start Over
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
- Source :
- Intestinal Research, Vol 16, Iss 2, Pp 168-177 (2018), Intestinal Research
- Publication Year :
- 2018
- Publisher :
- Korean Association for the Study of Intestinal Diseases, 2018.
-
Abstract
- Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.
- Subjects :
- medicine.medical_specialty
Consensus
Colorectal cancer
medicine.medical_treatment
lcsh:Medicine
Disease
Inflammatory bowel disease
digestive system
Colorectal neoplasms
Colitis, ulcerative
03 medical and health sciences
0302 clinical medicine
Epidemiology
medicine
Disease management (health)
lcsh:RC799-869
Intensive care medicine
Colectomy
business.industry
lcsh:R
Gastroenterology
Crohn disease
medicine.disease
Prognosis
Ulcerative colitis
digestive system diseases
Dysplasia
030220 oncology & carcinogenesis
030211 gastroenterology & hepatology
lcsh:Diseases of the digestive system. Gastroenterology
Statement
business
Subjects
Details
- Language :
- English
- ISSN :
- 22881956 and 15989100
- Volume :
- 16
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Intestinal Research
- Accession number :
- edsair.doi.dedup.....de2a4660d99f62f063ef5f6722754db4